34th Bethesda Conference: Task force #1--Identification of coronary heart disease risk: is there a detection gap?
about
Ischemic heart disease in women: a focus on risk factorsShould women be offered cholesterol lowering drugs to prevent cardiovascular disease? YesShould adults with type 2 diabetes be screened for atherosclerotic cardiovascular disease?Assessment and relevance of carotid intima-media thickness (C-IMT) in primary and secondary cardiovascular preventionCarotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study.Multicenter epidemiological studies of atherosclerosis imagingIndividual assessment of arteriosclerosis by empiric clinical profilingEvaluation of an exercise field test using heart rate monitors to assess cardiorespiratory fitness and heart rate recovery in an asymptomatic populationAtherothrombosis in South asians: implications of atherosclerotic and inflammatory markers.Intraindividual variability of C-reactive protein: the Multi-Ethnic Study of Atherosclerosis.Recent advances in the management of chronic stable angina I: approach to the patient, diagnosis, pathophysiology, risk stratification, and gender disparities.Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of CardiologyLipoprotein-associated phospholipase A2 and carotid intima-media thickness in individuals classified as low-risk according to Framingham.Myocardial ischemia in women: lessons from the NHLBI WISE study.The evolution and refinement of traditional risk factors for cardiovascular disease.Breast arterial calcifications as a cardiovascular risk marker in women.Adverse pregnancy outcomes and cardiovascular risk factor managementCardiorespiratory fitness and risk of nonfatal cardiovascular disease in women and men with hypertension.Women up, men down: the clinical impact of replacing the Framingham Risk Score with the Reynolds Risk Score in the United States population.Women and coronary artery disease. Part I: basic considerations.High prevalence of subclinical atherosclerosis by carotid ultrasound among Mexican Americans: discordance with 10-year risk assessment using the Framingham risk scoreValue of reserve pulse pressure in improving the risk stratification of patients with normal myocardial perfusion imagingEvaluation of heart rate recovery in patients with primary nephrotic syndrome.The use of high-sensitivity assays for C-reactive protein in clinical practice.Women's health in menopause with a focus on hypertensionImpact of adding a single allele in the 9p21 locus to traditional risk factors on reclassification of coronary heart disease risk and implications for lipid-modifying therapy in the Atherosclerosis Risk in Communities study.Metabolic syndrome, cardiovascular risk and screening for subclinical atherosclerosis.Women and ischemic heart disease: evolving knowledge.Assessment of Cardiovascular Risk Factors Among University Students: The Gender FactorEffect of adding a values clarification exercise to a decision aid on heart disease prevention: a randomized trial.Detection of coronary artery disease in postmenopausal women: the significance of integrated stress imaging tests in a 4-year prognostic study.Heart rate recovery is impaired in patients with psoriasisApplication of national screening criteria for blood pressure and cholesterol to perimenopausal women: prevalence of hypertension and hypercholesterolemia in the Study of Women's Health Across the Nation.High prevalence of subclinical atherosclerosis in Brazilian postmenopausal women with low and intermediate risk by Framingham score.Coronary calcification with no flow limiting lesions: A potential cause for ischaemic dysfunction in syndrome X patients.Association of serum gamma-glutamyltransferase and premature coronary artery disease.METEOR Trial Reports on the Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness in Low-Risk Individuals with Subclinical Atherosclerosis.Repeated measures of body mass index and C-reactive protein in relation to all-cause mortality and cardiovascular disease: results from the consortium on health and ageing network of cohorts in Europe and the United States (CHANCES).10-Year Resource Utilization and Costs for Cardiovascular Care.
P2860
Q22251459-3651C469-7531-4A76-9CAE-89C138D0C72CQ24685830-01C3ED28-6EB2-4AA7-9C88-60DC167E6716Q26851148-43A9ACF0-297A-4D0E-A474-55612571BCC1Q30358810-B4CD76F1-9D85-4A55-9522-B291EC050487Q30475835-DBE0922D-FDB0-4D2F-A109-C7CB83C43E9EQ30477074-3539EA21-19FB-43D5-A3EE-9CD51909CCD6Q33307524-06B858A3-8B22-4EE8-A33D-59F1F4CD20D7Q33645238-BB12ABC2-5BAF-44BD-9350-A46863068EAAQ33736211-3AAA7592-F563-4D9C-8618-DAC2E1AA9F1BQ33857000-F044A58A-6946-45DB-A93E-F049440E9137Q34068784-5AE1FCCD-DCF4-49CC-A9B2-E1E0AD4E7556Q34682870-585A64C5-4D36-4494-A461-A6EC6B36A13FQ34779570-CDFA38CB-7D98-42DB-BBC2-824A0183DA4BQ35816400-3F0A95DB-442E-4A16-949F-EABC6D4CFB32Q35848359-DEDC0579-9D41-4066-B22A-F9A4D39BA0BBQ35879099-6117D5ED-5D3F-49DF-A2C0-738388EAD3B3Q35893804-A389DC8E-B93B-4A41-BB09-0EB85DB20841Q35989066-1A9756D2-F977-4236-8A62-EC795BD92F9BQ36229706-44F270DD-DB8E-4EE8-9B2C-C5606F21F9E3Q36305112-9AB64584-98DF-4A3C-AA23-6BD62C0DADB3Q36941430-F980CE27-68EE-4C8E-A96A-B6CFC41BB1E5Q37009783-D6D1DEC5-BCA7-4FD0-A822-C6D65F09D8E4Q37078431-451B4E28-F19F-4DD8-97EC-46FEA4787186Q37090943-CC577797-CEB8-4B17-8BF7-657E63107058Q37101516-E0D6CDF1-C7BC-43C2-8AD1-F603571E6B73Q37408982-DF31F35D-B193-4BAE-AE5C-DEB4470893A3Q37417693-B8429569-189B-4AF2-873F-3CD575BCF2AFQ37462134-546231D4-ADA8-47EE-8270-8F4B426DDB39Q37711359-861C8E2F-47E3-473D-8204-D13D73AC61D6Q37718188-5F6DA347-E963-4C19-891D-86DE2210E093Q39103733-6ECCE7EF-F361-45AD-B920-3482A7B69D0FQ39375369-A44EFBFE-1801-4188-9EF2-3EBF9307CDEFQ40306023-57D2B702-2A94-4F5B-B37E-D0F4788F04C1Q40527056-FFF36944-4D6D-4E45-A16F-07D494D3FF90Q40963756-11DA4241-F7CC-46DD-88BF-FCCF0696C57BQ41038159-1BE33E21-28D7-451F-B271-AD9203AFE980Q42970096-F36F110F-DCAB-458E-9297-72A2B096D1A0Q45007527-9D8EFFF1-49AC-455E-90B5-EB9EF5E93B72Q52666119-93166000-072F-49EA-BBA1-2BF464C34E18
P2860
34th Bethesda Conference: Task force #1--Identification of coronary heart disease risk: is there a detection gap?
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
34th Bethesda Conference: Task ...... isk: is there a detection gap?
@ast
34th Bethesda Conference: Task ...... isk: is there a detection gap?
@en
type
label
34th Bethesda Conference: Task ...... isk: is there a detection gap?
@ast
34th Bethesda Conference: Task ...... isk: is there a detection gap?
@en
prefLabel
34th Bethesda Conference: Task ...... isk: is there a detection gap?
@ast
34th Bethesda Conference: Task ...... isk: is there a detection gap?
@en
P2093
P1476
34th Bethesda Conference: Task ...... isk: is there a detection gap?
@en
P2093
Jonathan Abrams
Lynn A Smaha
Nancy Houston-Miller
Peter W F Wilson
Philip Greenland
Richard C Pasternak
P304
P356
10.1016/S0735-1097(03)00358-9
P407
P577
2003-06-01T00:00:00Z